These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15761419)
1. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. Méndez M; Rossetti MV; Del C Batlle AM; Parera VE J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419 [TBL] [Abstract][Full Text] [Related]
2. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242 [TBL] [Abstract][Full Text] [Related]
3. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study. Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803 [TBL] [Abstract][Full Text] [Related]
4. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340 [TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent. Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243 [TBL] [Abstract][Full Text] [Related]
6. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France. Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection. Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032 [TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients. Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996 [TBL] [Abstract][Full Text] [Related]
9. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients. Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935 [TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency. Egger NG; Goeger DE; Payne DA; Miskovsky EP; Weinman SA; Anderson KE Dig Dis Sci; 2002 Feb; 47(2):419-26. PubMed ID: 11855561 [TBL] [Abstract][Full Text] [Related]
12. Association of porphyria cutanea tarda with hereditary hemochromatosis. Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838 [TBL] [Abstract][Full Text] [Related]
13. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients]. Wolff CF; Armas RM; Frank J; Poblete PG Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171 [TBL] [Abstract][Full Text] [Related]
14. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection. Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887 [TBL] [Abstract][Full Text] [Related]
15. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda. Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625 [TBL] [Abstract][Full Text] [Related]
16. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661 [TBL] [Abstract][Full Text] [Related]
17. [Porphyria cutanea tarda. An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain]. Castiella A; Zapata E; de Juan MD; Múgica F; Barrio J; Otazua P; Arriola JA; Cosme A; Elosegui E; Fernández J; Zubiaurre L; Alzate LF; Utrilla E; Rev Esp Enferm Dig; 2008 Dec; 100(12):774-8. PubMed ID: 19222337 [TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C, hemochromatosis and porphyria cutanea tarda]. Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178 [TBL] [Abstract][Full Text] [Related]